Table 1.
Demographic data, Scoring systems and MACR at the beginning of the study
| Control | moderate dose | High dose | Sig. | ||
|---|---|---|---|---|---|
| Age(years) |
49.33333 ± 5.30 |
39.86667 ± 5.51 |
48.33333 ± 5.29 |
NS |
|
| sex |
Male |
13 (86%) |
13 (86%) |
13 (86%) |
NS |
| Female |
2 (14%) |
2 (14%) |
2 (14%) |
NS |
|
| Mortality rate |
6 (40%) |
7 (46.7%) |
5 (33.3%) |
NS |
|
| APACHE II(0 h) |
21.06 ± 0.69 |
21.20 ± 0.56 |
21.26 ± 0.58 |
NS |
|
| SOFA(0 h) |
8.33 ± 0.30 |
8.53 ± 0.44 |
8.20 ± 0.29 |
NS |
|
| TNFα (pg/ml)(0 h) |
36.37 ± 11.77 |
34.16 ± 9.99 |
32.71 ± 11.42 |
NS |
|
| TBARS (μM)(0 h) |
3.89 ± 0.65 |
4.27 ± 1.44 |
3.76 ± 1.32 |
NS |
|
| FRAP (μM) |
402.44 ± 65.33 |
399.61 ± 71.83 |
448.87 ± 85.03 |
NS |
|
| MACR(0 h)* | 30.21 ± 5.69 | 27.59 ± 5.35 | 29.53 ± 5.35 | NS | |
APACHE = Acute Physiology and Chronic Health Evaluation, SOFA = Sequential Organ Failure Assessment, MACR = microalbumin to creatinine ratio. * mg/mmol.